General Information of Drug (ID: DMKMU2S)

Drug Name
GNX102 Drug Info
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMKMU2S

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Tumor-associated glycan antigen (TAGA) TTZUFEL NOUNIPROTAC Not Available [2]

References

1 ClinicalTrials.gov (NCT04250597) Study of GNX102 in Patients With Advanced Solid Tumors. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of GlycoNex.